Mendez-Gonzalez Diego, Lifante José, Zabala Gutierrez Irene, Marin Riccardo, Ximendes Erving, Sanz-de Diego Elena, Iglesias-de la Cruz M Carmen, Teran Francisco J, Rubio-Retama Jorge, Jaque Daniel
Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramon y Cajal 2, Madrid, 28040, Spain.
Nanobiology Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. De Colmenar Viejo, Km. 9100, Madrid, 28034, Spain.
Nanoscale. 2022 Nov 10;14(43):16208-16219. doi: 10.1039/d2nr03413a.
Optomagnetic nanofluids (OMNFs) are colloidal dispersions of nanoparticles (NPs) with combined magnetic and optical properties. They are especially appealing in biomedicine since they can be used as minimally invasive platforms for controlled hyperthermia treatment of otherwise difficultly accessible tumors such as intracranial ones. On the one hand, magnetic NPs act as heating mediators when subjected to alternating magnetic fields or light irradiation. On the other hand, suitably tailored luminescent NPs can provide a precise and remote thermal readout in real time. The combination of heating and thermometric properties allows, in principle, to precisely monitor the increase in the temperature of brain tumors up to the therapeutic level, without causing undesired collateral damage. In this work we demonstrate that this view is an oversimplification since it ignores the presence of relevant interactions between magnetic (γ-FeO nanoflowers) and luminescent nanoparticles (AgS NPs) that result in a detrimental alteration of their physicochemical properties. The magnitude of such interactions depends on the interparticle distance and on the surface properties of nanoparticles. Experiments performed in mouse brains (phantoms and ) revealed that OMNFs cannot induce relevant heating under alternating magnetic fields and fail to provide reliable temperature reading. In contrast, we demonstrate that the use of luminescent nanofluids (containing only AgS NPs acting as both photothermal agents and nanothermometers) stands out as a better alternative for thermally monitored hyperthermia treatment of brain tumors in small animal models.
Nanoscale. 2022-11-10
ACS Appl Mater Interfaces. 2016-9-13
J Biomed Mater Res B Appl Biomater. 2017-9-15
Front Bioeng Biotechnol. 2023-7-21